THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Ironwood Pharmaceuticals plans IPO

Cambridge firm developing drug for bowel ailment

Ironwood did not specify in yesterday’s filing how much it plans to raise by selling stock. Ironwood did not specify in yesterday’s filing how much it plans to raise by selling stock. (John Tlumacki/Globe Staff/File)
By Todd Wallack
Globe Staff / November 21, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Ironwood Pharmaceuticals, a Cambridge biotechnology company developing a treatment for irritable bowel syndrome, yesterday filed plans to go public. (Full article: 355 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass